Sevabertinib
About
Therapy type: Targeted therapy
Therapy strategy: EGFR inhibition, HER2 inhibition
Mappings
NCI Thesaurus: None (ncit:C185187)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | ERBB2 TKD activating variants | Lung Non-Squamous Non-Small Cell Carcinoma | Sevabertinib |